Evidence map›Paper›PMID 41809411›Full record

ArticleClinical interventions in aging2026

The Shifting Prognostic Value of Performance Status in Aging Glioblastoma Patients: A Retrospective Cohort Study.

Qiushi Zhang, Lei Zhang, Haiying Liu, Lize Chen, Shiduo Li, Xiaoyan Gao, Jason H Huang, Erxi Wu, Jing Tong

Abstract read
In one paragraph

Article in Clinical interventions in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qiushi Zhang *Department of Neurosurgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Lei Zhang *Department of Neurosurgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Haiying LiuDepartment of Neurosurgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Lize ChenDepartment of Neurosurgery, Northwest University First Hospital, Xian, Shaanxi, People's Republic of China.
Shiduo LiDepartment of Neurosurgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Xiaoyan GaoDepartment of Neurosurgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Jason H HuangDepartment of Neurosurgery, Baylor Scott & White Health, Temple, TX, USA.
Erxi WuDepartment of Neurosurgery, Baylor Scott & White Health, Temple, TX, USA.
Jing TongDepartment of Neurosurgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate how advancing age affects the prognostic value of preoperative versus postoperative Karnofsky Performance Status (KPS) for guiding clinical interventions in glioblastoma (GBM) patients aged 60 and older. Patients and Methods: This retrospective cohort study included 89 patients (≥60 years) with newly diagnosed GBM treated between 2017 and 2021. We analyzed demographic, clinical, and treatment data, identifying prognostic factors for overall survival (OS) via Cox proportional hazards models. The utility of preoperative and postoperative KPS was assessed in age-stratified subgroups (60-64, 65-69, and ≥70 years) using Kaplan-Meier analysis. Results: Multivariable analysis confirmed greater extent of resection (P<0.001), higher postoperative KPS (HR: 0.981, P=0.006), and chemoradiation (P<0.001) as independent predictors of improved OS. Age-stratified analysis revealed that preoperative KPS was prognostic only in the "young-elderly" group (60-64 years, P=0.003), losing its predictive power in patients aged ≥65. In contrast, postoperative KPS remained a robust and consistent prognostic indicator across all elderly age groups (P≤0.001 for all). Conclusion: The prognostic utility of preoperative KPS diminishes significantly after age 65, suggesting its use as a standalone determinant for aggressive interventions should be reconsidered in the older-elderly. Postoperative KPS, however, is a powerful predictor across the aging spectrum. These clinical-only findings underscore that interventions preserving functional status are critical to improving outcomes in this aging population.

Indexed as

AgingBrain NeoplasmsGlioblastomaKarnofsky Performance StatusAgedAge FactorsFemaleHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisProportional Hazards ModelsRetrospective Studiesclinical decision-makingfunctional statusgeriatric oncologyglioblastomakarnofsky performance scaleprognosis

Identifiers

PMID41809411
PMCPMC12970025

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.